Somryst (digital CBT-I)
FDA-cleared digital CBT-I, available by prescription in the United States.
- What it is
- FDA-cleared digital CBT-I, available by prescription in the United States.
- Best for
- Chronic insomnia treatment · Cognitive behavioral therapy · Structured digital monitoring
- Platforms
- iOS · Android
Strengths
- FDA-cleared digital CBT-I (United States)
- Structured program format
Weak points
- Original publisher in bankruptcy (2023), status requires verification
- Not available in France or Canada
What is Somryst (digital CBT-I)?
Somryst is a prescription-only digital therapeutic intended to treat chronic insomnia in adults 22 years and older. The program is based on cognitive behavioral therapy for insomnia principles, aimed at modifying behaviors and routines associated with sleep difficulties. The tool is a mobile application accessible via smartphone or tablet. It features a structured six-module training program, supplemented by a daily sleep diary to personalize the therapeutic support over a 6 to 9 week period.
At a glance
- Type
- Digital CBT-I
- Platforms
- iOS, Android
- Subscription required
- No
- Free trial
- No
- French
- No
- Availability
- United States
- Uses AI
- No
- Evidence level
- Published studies
This information is indicative and may change: only the publisher's own website is authoritative.
Who uses Somryst (digital CBT-I)?
Adults with insomnia
The program is intended for individuals 22 years of age and older suffering from chronic insomnia.
Patients under care
Use must occur under the supervision of a healthcare professional authorized to prescribe this device.
Key features
Training modules
The program includes six interactive modules designed for learning and developing skills related to sleep.
Sleep diary
Users enter their sleep habits daily to allow for personalized treatment adjustments.
Mobile access
The therapy is delivered via a mobile application, allowing for flexible use on a smartphone or tablet.
Pricing
Available only by prescription in the United States; cost is determined by the patient's health system or insurance.
Pricing recorded on October 28, 2026. Excluding taxes and shipping. Prices change: the amount that applies is the one shown by the publisher's own checkout.
Therapeutic program
Not disclosed
Access limited to the duration of the medical prescription.
- 6 training modules
- Daily sleep diary
- Cognitive behavioral therapy for insomnia (CBT-I)
Access to Somryst requires a prescription from a healthcare professional. It is recommended to consult a doctor to determine if this device is appropriate for your clinical situation.
Use cases
Insomnia management
Use of cognitive behavioral therapy techniques to target behavioral factors.
Outcome: Reduction of maladaptive behaviors related to sleep.
How it works in practice
Therapeutic pathway
- 1Obtain a medical prescription
- 2Install the mobile application
- 3Complete the 6 training modules
- 4Daily entry of sleep diary
In your daily routine
Mobile compatibility
The application is designed to function on standard mobile devices such as smartphones and tablets.
Known limits
Geographic access
The device is intended for residents of the United States and requires a local prescription.
Restricted usage
The program is reserved for adults 22 years and older.
Consider something else if
- Non-prescription therapy programs
- Consumer sleep tracking applications
- Sleep medicine consultations
How to use it
Prescription
Consult a healthcare professional to obtain a valid prescription for this digital device.
Commitment
Plan for approximately 45 to 60 minutes per week for modules, in addition to daily time for the diary.
Frequently asked questions
Is Somryst a sleep aid?+
No, Somryst is a sleep training program based on cognitive behavioral therapy.
Is a prescription required to use it?+
Yes, Somryst is a digital therapeutic device available only by prescription.
What is the duration of the program?+
The program lasts for a period of 6 to 9 weeks.
On which devices does the application work?+
The application is compatible with smartphones and tablets.
Is the program available in French?+
No, the application content is currently available in English only.
Sources
Evidence level shown: Published studies
Digital CBT-I program that underwent a randomized controlled trial with one-year follow-up, and cleared as a digital treatment by the FDA.
No published source specific to this product has been identified so far.
Background on the approach
General references on the category or technology: they do not cover this specific product.
- 1.Ritterband L.M. et al., randomized controlled trial of online CBT-I, JAMA Psychiatry, 2017
- 2.Zachariae R. et al., Efficacy of internet-delivered cognitive-behavioral therapy for insomnia, Sleep Medicine Reviews, 2016
- 3.Edinger J.D. et al., Behavioral and psychological treatments for chronic insomnia disorder in adults, Journal of Clinical Sleep Medicine (AASM), 2021
- 4.FDA 510(k) clearance K191716 (Somryst)
These references cover the approach or technology, not an evaluation of the product by us. None of these links is an affiliate link. Read our method.
Explore by topic
Similar tools
NOXXEA
French digital medical device: 4-week CBT-I program, prescribed by a healthcare professional.
ThéraSomnia
French online CBT-I program, supported by a 2016 study conducted at the Montpellier Hospital.
Insomnia Coach
Free autonomous version for applying CBT-I principles: diary, 5-week plan, and tips.
CBT-i Coach
Free application from the U.S. Department of Veterans Affairs, designed to support CBT-I with a therapist.
Sleep Reset
Program based on CBT-I with coach (human and AI) and sleep log.
Stellar Sleep
App combining CBT-I and Acceptance and Commitment Therapy, with personalized coaching.